MARKET

GRMLW

GRMLW

Greenland Mines Ltd
NASDAQ
0.2026
-0.0724
-26.33%
After Hours: 0.1700 -0.0326 -16.09% 17:07 06/12 EDT
OPEN
0.2400
PREV CLOSE
0.2750
HIGH
0.3000
LOW
0.2026
VOLUME
29.20K
TURNOVER
--
52 WEEK HIGH
0.9500
52 WEEK LOW
0.0300
MARKET CAP
--
P/E (TTM)
-0.6041
1D
5D
1M
3M
1Y
5Y
1D
Greenland Mines strengthens collaboration with Reykjanes Investment
TipRanks · 3d ago
Greenland Mines signs updated Helguvik LoI with Reykjanes Investment, secures first refusal on Iceland site
PUBT · 3d ago
GREENLAND MINES EXECUTES STRATEGIC DOWNSTREAM AGREEMENT ON HELGUVIK INDUSTRIAL COMPLEX IN ICELAND
Reuters · 3d ago
Weekly Report: what happened at GRML last week (0601-0605)?
Weekly Report · 5d ago
Greenland Mines completes site visit after deal to buy Neo North Star, owner of Sarfartoq rare earths project
PUBT · 06/04 12:49
Greenland Mines agrees to buy Neo North Star, adding Sarfartoq rare-earths project
PUBT · 06/02 13:10
Greenland Mines taps WSP Denmark for Sarfartoq rare earth baseline studies in Greenland
PUBT · 06/02 12:31
Greenland Mines Appoints WSP Denmark to Continue Environmental Baseline Work at the Sarfartoq Rare Earth Project
PR Newswire · 06/02 12:30
More
About GRMLW
ANEW Medical, Inc. is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The Company has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.

Webull offers ANEW Medical Inc stock information, including NASDAQ: GRMLW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRMLW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRMLW stock methods without spending real money on the virtual paper trading platform.